🇺🇸 FDA
Patent

US 12233087

Palladium hyaluronic acid particles and methods of managing cancer or angiogenic conditions

granted A61KA61K31/12A61K31/56

Quick answer

US patent 12233087 (Palladium hyaluronic acid particles and methods of managing cancer or angiogenic conditions) held by The United States Government represented byt The United States Department of Veterans Affairs expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States Government represented byt The United States Department of Veterans Affairs
Grant date
Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/12, A61K31/56, A61K31/728, A61K33/24